Watch Point Trust Co boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 36.0% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,253 shares of the medical research company’s stock after purchasing an additional 1,921 shares during the period. Watch Point Trust Co’s holdings in Thermo Fisher Scientific were worth $1,985,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in TMO. Kentucky Retirement Systems purchased a new position in shares of Thermo Fisher Scientific during the 3rd quarter worth approximately $3,322,000. Neuberger Berman Group LLC boosted its position in shares of Thermo Fisher Scientific by 35.6% in the 3rd quarter. Neuberger Berman Group LLC now owns 210,762 shares of the medical research company’s stock worth $51,443,000 after purchasing an additional 55,336 shares in the last quarter. B. Riley Wealth Management Inc. bought a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth approximately $2,468,000. Lombard Odier Asset Management USA Corp bought a new stake in shares of Thermo Fisher Scientific in the 3rd quarter worth approximately $2,441,000. Finally, Legal & General Group Plc boosted its position in shares of Thermo Fisher Scientific by 4.0% in the 3rd quarter. Legal & General Group Plc now owns 1,847,206 shares of the medical research company’s stock worth $450,856,000 after purchasing an additional 70,872 shares in the last quarter. Institutional investors own 88.66% of the company’s stock.

NYSE TMO opened at $259.78 on Monday. The firm has a market cap of $103.65 billion, a PE ratio of 23.36, a PEG ratio of 1.71 and a beta of 1.13. The company has a current ratio of 1.73, a quick ratio of 1.24 and a debt-to-equity ratio of 0.64. Thermo Fisher Scientific Inc. has a 1-year low of $202.83 and a 1-year high of $282.98.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, January 30th. The medical research company reported $3.25 earnings per share for the quarter, beating the consensus estimate of $3.19 by $0.06. The firm had revenue of $6.51 billion for the quarter, compared to analysts’ expectations of $6.26 billion. Thermo Fisher Scientific had a return on equity of 16.86% and a net margin of 12.06%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.79 EPS. As a group, analysts forecast that Thermo Fisher Scientific Inc. will post 12.16 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, April 16th. Stockholders of record on Friday, March 15th were issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.29%. This is a boost from Thermo Fisher Scientific’s previous quarterly dividend of $0.17. The ex-dividend date of this dividend was Thursday, March 14th. Thermo Fisher Scientific’s dividend payout ratio is presently 6.83%.

A number of analysts have recently commented on TMO shares. UBS Group boosted their price target on Thermo Fisher Scientific to $305.00 and gave the stock a “buy” rating in a research report on Monday, March 25th. BTIG Research upped their price objective on Thermo Fisher Scientific to $290.00 and gave the company a “buy” rating in a research report on Thursday, January 31st. Barclays upped their price objective on Thermo Fisher Scientific from $295.00 to $300.00 and gave the company an “overweight” rating in a research report on Monday, March 18th. Needham & Company LLC initiated coverage on Thermo Fisher Scientific in a research report on Wednesday, January 2nd. They issued a “strong-buy” rating and a $271.00 price objective on the stock. Finally, Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, January 5th. Two equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus target price of $289.92.

In other news, insider Gregory J. Herrema sold 3,299 shares of the company’s stock in a transaction on Friday, March 1st. The stock was sold at an average price of $263.05, for a total value of $867,801.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the company’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $266.00, for a total value of $665,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 36,927 shares of company stock worth $9,388,124 over the last three months. Insiders own 0.49% of the company’s stock.

WARNING: “Thermo Fisher Scientific Inc. (TMO) Shares Bought by Watch Point Trust Co” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.watchlistnews.com/thermo-fisher-scientific-inc-tmo-shares-bought-by-watch-point-trust-co/2981047.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Featured Article: Capital Gains

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.